Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
12/2010
12/01/2010CN101899011A Dithiocarbamates compound, preparation method and application thereof
12/01/2010CN101899010A Quinazol derivative, preparation method and application thereof
12/01/2010CN101899009A Method for preparing pharmaceutical intermediate 4(H) quinnazolidone
12/01/2010CN101899008A N-substituted pyrimidine sulfonyl-substituted benzamide type small molecular inhibitor for Bcl-2 protein and application thereof
12/01/2010CN101898982A Npy y5 antagonists
12/01/2010CN101898925A Green synthesis and industrialization method of chloro-substituted heterocyclic ring
12/01/2010CN101353327B Aryl substituted pyrimidine spirobifluorene derivative and preparation thereof
11/2010
11/30/2010US7842807 Process for preparing the calcium salt of rosuvastatin
11/30/2010CA2615692C Process for converting an alcohol to the corresponding fluoride
11/30/2010CA2513440C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
11/30/2010CA2144474C Substituted n-ethylglycine derivatives for preparing pna and pna/dna hybrids
11/25/2010WO2010135070A1 Compounds and methods for controlling fungi
11/25/2010WO2010134533A1 2,4-diaminopyrimidine compound having aminocyclohexylalkyl group
11/25/2010WO2010134014A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010WO2010133885A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010WO2010133882A1 Disaccharin, difumaric acid, di-l-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamin0)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin- 5 -yl) methyl) phenyl)acetate
11/25/2010WO2010133312A1 Halogen-substituted compounds as pesticides
11/25/2010WO2010132992A1 Compounds for the inhibition of herpesviruses
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2010085128A3 Processes for preparing hiv reverse transcriptase inhibitors
11/25/2010WO2010027448A8 Isotopically enriched pyrimidin-5-yl acetic acid derivatives as crth2 antagonists
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010WO2009121042A8 Quinazoline derivatives and methods of treatment
11/25/2010US20100298567 Nitration of activated aromatics in microreactors
11/25/2010US20100298364 salts 756
11/25/2010US20100298362 Process for the preparation of 4-[6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
11/25/2010US20100298361 Alkylthio Pyrimidines As CRTH2 Antagonists
11/25/2010US20100298358 Naphthamide Derivatives As Multi-Target Protein Kinase Inhibitors and Histone Deacetylase Inhibitors
11/25/2010US20100298356 Saturated and insaturated bi- or tricyclic aryloxyacetamine derivatives and their use as fungicides
11/25/2010US20100298344 Polycationic Compounds And Uses Thereof
11/25/2010US20100298336 Pyrimidines as novel therapeutic agents
11/25/2010US20100298331 Triazinone and diazinone derivatives useful as hsp90 inhibitors
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298267 Aminopyrimidinamides as pesticides
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100298143 Compounds and methods for controlling fungi
11/25/2010US20100297034 Osmolyte-containing preparation for use in case of dry mucous membranes
11/25/2010CA2760911A1 Compounds and methods for controlling fungi
11/25/2010CA2760885A1 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
11/25/2010CA2760766A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010CA2760765A1 Disaccharin, difumaric acid, di-1-hydroxy-2-naphthoic acid and mono-benzoic acid salts of 4- (dimethylamino)butyl 2- (4- ( (2-amino-4-methyl-6- (pentylamino) pyrimidin-5-yl) methyl) phenyl)acetate
11/24/2010EP2253618A1 Compound having 6-membered aromatic ring
11/24/2010EP2253617A1 Halogenated compounds as pesticides
11/24/2010EP2253616A1 Process for the preparation of compounds capable of activating cholinergic receptors
11/24/2010EP2253328A1 Cycloalkyl inhibitors of potassium channel function
11/24/2010EP2252595A1 Oxim derivatives as hsp90 inhibitors
11/24/2010EP2252594A2 5-fluoro pyrimidine derivatives as fungicides
11/24/2010EP2252277A2 Acetyl mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
11/24/2010EP1615897B1 Pyrimidinone compounds as calcilytics
11/24/2010EP1583972B1 Methods for identifying drug non-target proteins
11/24/2010EP1280764B1 Inhibitors of histone deacetylase
11/24/2010CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
11/24/2010CN101896473A Inhibitors of stearoyl-coa desaturase
11/24/2010CN101896180A Combination 059
11/24/2010CN101891691A Method for preparing erlotinib hydrochloride
11/24/2010CN101891690A Synthesis method of N-substituted-4-amino-quinazoline compound
11/24/2010CN101890018A Tyrosine protein kinase inhibitor and preparation method thereof
11/24/2010CN101155787B (3,4-dihydro-quinazolin-2-yl)-indan-1-yl-amines
11/23/2010US7838674 2-(1-amino-cyclobutylmethyl)-8-(4-methoxy-phenyl)-4,5-dihydro-1 H-1,7,9-triazacyclopenta[a]naph-thalene-3-carboxylic acid lactame; useful especially as inhibitors of mitogen-activated protein kinase-activated protein kinase-2 (MK2 or MAPKAP kinase-2
11/23/2010US7838530 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838520 Inhibitors of histone deacetylase
11/18/2010WO2010132508A2 Compositions and methods for biological sample storage
11/18/2010WO2010131118A2 Polymorphs of etravirine and processes for preparation thereof
11/18/2010WO2010130900A2 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors
11/18/2010WO2010102824A3 Sodium salt of 5-cyclopropyl-2-{[2-(2,6- difluorophenyl)pyrimidin-5-yl]amino}benzoic acid as dhodh inhibitor
11/18/2010WO2010065586A3 Preparation of capecitabine
11/18/2010WO2010033168A3 Modulators of p2x3 receptor activity
11/18/2010WO2010017466A3 Phenobarbital salts; methods of making; and methods of use thereof
11/18/2010WO2009115267A3 Diaminopyrimidines as plant protection agents
11/18/2010US20100292500 Npy y5 antagonist
11/18/2010US20100292474 Di-alkyl substituted imidazoline derivatives
11/18/2010US20100292260 6-vinyl pyrimidine and pyrimidinone derivatives and the use thereof
11/18/2010US20100292239 Novel microbiocides
11/18/2010US20100292203 Heterocyclic aspartyl protease inhibitors
11/18/2010US20100290992 Nanoparticle nucleic acid binding compound conjugates forming i-motifs
11/18/2010CA2761675A1 Compositions and methods for biological sample storage
11/17/2010EP2251333A1 Biphenyl derivatives as P-38 kinase inhibitors
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2251324A1 Heteroaryl-alkylcarbamate compounds and their use as inhibitors of the faah enzyme
11/17/2010EP2250155A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
11/17/2010EP1585522B1 Quinazolinones as potassium channel modulators
11/17/2010EP1032377B1 Substituted 2-aminoacetamides and the use thereof
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101888999A Pyridylmethyl-sulfonamide compounds
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101367769B N-(2-pyrimidine oxygen based) benzyl amide compounds, preparation method and uses thereof
11/17/2010CN101177413B 6-cyclohexyl methyl substituted S-DABO compound, method for synthesizing same and uses thereof
11/16/2010US7834043 Prevent reproduct of aids virus
11/16/2010US7834026 histone deacetylase inhibitors; antiproliferative; antineoplastic; thioredoxin (TRX)-mediated diseases such as autoimmune, allergy, inflammatory diseases; and neurodegenerative diseases; N-(2-Aminophenyl)-6-(4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-8-yl)nicotinamide; hydroxamic acid moiety
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834000 CGRP receptor antagonists
11/16/2010US7833940 weed control against broadleaf weeds as well as grass and sedge weeds and with excellent crop selectivity at low use rates; excellent toxicological or environmental profiles
11/16/2010CA2686429C Processes for the preparation of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
11/16/2010CA2611572C Preparations containing amino acids and orotic acid
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
11/16/2010CA2416535C Non-sedating barbiturate compounds as neuroprotective agents
11/11/2010WO2010129848A2 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
11/11/2010WO2010129802A1 Inhibitors of jak
1 ... 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 ... 427